LBLTF (Lattice Biologics) Total Assets: $0.61 Mil (As of Jun. 2021)


What is Lattice Biologics Total Assets?

Lattice Biologics LBLTF -99.00% Total Assets is $0.61 Mil as of Jun. 2021.

Lattice Biologics's Total Assets for the quarter that ended in Jun. 2021 was $0.61 Mil.

Total Assets is connected with ROA %. Lattice Biologics's annualized ROA % for the quarter that ended in Jun. 2021 was -16.80%. Total Assets is also linked to Revenue through Asset Turnover. Lattice Biologics's Asset Turnover for the quarter that ended in Jun. 2021 was 0.00.

Lattice Biologics  (OTCPK:LBLTF) Total Assets Explanation

Total Assets is connected with ROA %.

Lattice Biologics's annualized ROA % for the quarter that ended in Jun. 2021 is

ROA %=Net Income (Q: Jun. 2021 )/( (Total Assets (Q: Mar. 2021 )+Total Assets (Q: Jun. 2021 ))/ count )
=-0.104/( (0.632+0.606)/ 2 )
=-0.104/0.619
=-16.80 %

Note: The Net Income data used here is four times the quarterly (Jun. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Lattice Biologics's Asset Turnover for the quarter that ended in Jun. 2021 is

Asset Turnover
=Revenue (Q: Jun. 2021 )/( (Total Assets (Q: Mar. 2021 )+Total Assets (Q: Jun. 2021 ))/ count )
=0/( (0.632+0.606)/ 2 )
=0/0.619
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Lattice Biologics Total Assets Related Terms

Lattice Biologics Total Assets Historical Data

* Premium members only.

The historical data trend for Lattice Biologics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lattice Biologics Total Assets Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.62 3.45 3.07 2.28 3.02

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.48 3.02 2.87 0.63 0.61

Lattice Biologics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Lattice Biologics's Total Assets for the fiscal year that ended in Sep. 2020 is calculated as

Total Assets=Total Equity (A: Sep. 2020 )+Total Liabilities (A: Sep. 2020 )
=-6.401+9.419
=3.02

Lattice Biologics's Total Assets for the quarter that ended in Jun. 2021 is calculated as

Total Assets=Total Equity (Q: Jun. 2021 )+Total Liabilities (Q: Jun. 2021 )
=0.101+0.506
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.61 Mil mean?
Lattice Biologics (LBLTF) has a Total Assets of $0.61 Mil as of Jun. 2021. The total amount of assets as recorded on a company's balance sheet. View historical data on Lattice Biologics and its competitors.
Is Lattice Biologics' Total Assets too high?
Lattice Biologics' current Total Assets is $0.61 Mil.
How does Lattice Biologics' Total Assets compare to ABT and MDT?
Lattice Biologics' Total Assets of $0.61 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Lattice Biologics and its competitors. Lattice Biologics's current Total Assets is $0.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lattice Biologics stock overvalued right now?
Lattice Biologics (LBLTF) has a current Total Assets of $0.61 Mil. The current Total Assets is $0.61 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Lattice Biologics (LBLTF), the current Total Assets is $0.61 Mil as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lattice Biologics Business Description

Address 512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The company's products include ADM dermis, DBM Putty, Bone scaffold, and others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.